WHAT IS THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER?

1 Herget EJ, Saliken JC, Donnelly BJ, Gray RR, Wiseman D, Brunet G. Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can Assoc Radiol J 1999; 50 : 173–6 2 Connor SE, Wingate JP. Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy: a survey of current practice amongst radiologists and urologists. Clin Radiol 1999; 54 : 598–603 3 Ala-Opas MY, Gronlund SS. Blood loss in long-term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol 1996; 30 : 203–6 4 Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J. The effect of low dose acetylsalicylic acid on bleeding after transurethral prostatectomy – a prospective, randomized double blind, placebocontrolled study. Scan J Urol Nephrol 2000; 34 : 194–8 5 Enver MK, Hoh I, Chinegwundoh FI. The management of aspirin in transurethral prostatectomy: current practice in the UK. Ann R Coll Surg Engl 2006; 88 : 280–3 6 Fijnheer R, Urbanus RT, Nieuwenhuis HK. [Withdrawing the use of acetylsalicylic acid prior to an operation usually not necessary]. Ned Tijdschr Geneeskd 2003; 147 : 21–5 7 Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med 2005; 257 : 399–414 8 Weightman WM, Gibbs NM, Weidmann CR et al. The effect of preoperative aspirin-free interval on red blood cell transfusion requirements in cardiac surgical patients. J Cardiothorac Vasc Anesth 2002; 16 : 54–8